This expertise is supported by a large portfolio of well validated in vitro and in vivo models, a range of often unique read-out parameters and an extensive academic and clinical network.

Representative disease models are very useful in obtaining important information in the following areas:

• Efficacy
• Compound prioritization
• Target identification
• Target validation
• Mechanism of action